Title: Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive
Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter,
Randomized, Double-blind, Non-inferiority Study
Version: 6 Date: 29 Nov 2023
Reviewer's report:
Authors sufficiently respond my comments.
I would like to wait their next RCT: esomeprazole vs tegoprazan.
Title: Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive
Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter,
Randomized, Double-blind, Non-inferiority Study
Version: 6 Date: 29 Nov 2023
Reviewer's report:
Authors sufficiently respond my comments.
I would like to wait their next RCT: esomeprazole vs tegoprazan.
Please review this paper.
user
Title: Efficacy and Safety of HIP1601 (Dual Delayed-release Esomeprazole) 40mg in Erosive
Esophagitis Compared to HGP1705 (Delayed-release Esomeprazole) 40mg: A Multicenter,
Randomized, Double-blind, Non-inferiority Study
Version: 6 Date: 29 Nov 2023
Reviewer's report:
Authors sufficiently respond my comments.
I would like to wait their next RCT: esomeprazole vs tegoprazan.
assistant